You don't have permission to access "http://www.medpagetoday.com/pediatrics/generalpediatrics/118488" on this server. Reference #18.af2d3e17.1763024509.615a5ef9 https://errors.edgesuite.net/18.af2d3e17.1763024509.615a5ef9
Please complete security verification This request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our support team. 185.149.70.50 : ee4cfcb2-1632-4c0c-bd74-51630f57
Share on PinterestNew research indicates that patients taking certain high blood pressure medications are less likely to develop severe COVID-19 or die.Early in the COVID-19 pandemic, there were concerns that a type of drug primarily used for treating hypertension (high blood pressure) might worsen the infection.The drugs in question are angiotensin-converting enzyme inhibitors (ACE inhibitors)…
Certain high blood pressure medications may help reduce the severity of disease and mortality rates for those infected with the novel coronavirus, according to a new study published in the journal Current Atherosclerosis Reports.Researchers from the University of East Anglia looked at 19 studies in the meta-analysis involving approximately 28,000 patients who took antihypertension medications such as Angiotensin-Converting Enzyme inhibitors…
Medication for high blood pressure lowers the risk of becoming seriously ill or dying from Covid-19 by one third, a study suggests. Researchers from the University of East Anglia studied 28,000 patients taking antihypertensives, a class of drugs used to treat high blood pressure. They found that the risk of severe Covid-19 illness and death…
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.